ロード中...
A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia
The isoflavone ME-344 is a potent anti-cancer agent with preclinical and clinical efficacy in solid tumors. Yet, the mechanism of action of ME-344 has not been fully defined and the preclinical efficacy in leukemia has not been established. Therefore, we investigated the anti-leukemic properties and...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226547/ https://ncbi.nlm.nih.gov/pubmed/27391350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10446 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|